Insulin-like growth factor 2 (IGF2) can activate tyrosine kinase upregulation by binding to IGF1, and it also leads to a decrease in the activity of insulin receptor substrate (IRS1), which can result in the development of diabetes (Su et al., 2016). Here, IGF2 is linked to diabetes mellitus.